Opdivo 240 MG/24 ML vial 24ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0YH7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,997
Award facts
- Contract value 100% obligated
- $32,997.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $32,997.18 to AmerisourceBergen Drug Corp for the supply of OPDIVO 240 mg/24 mL vials. This firm fixed price contract, issued on December 16, 2025, with an ultimate completion date of January 8, 2026, represents a competitively awarded, non-set-aside procurement with performance directed to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. OPDIVO is a critical immunotherapy pharmaceutical used in the treatment of various cancers, and its procurement through DLA reflects the ongoing medical supply needs of the Defense Health Agency and military healthcare systems.
This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen maintains a comprehensive portfolio of federal medical supply contracts with DLA, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military and veteran healthcare systems globally. The company's consistent receipt of competitively awarded delivery orders demonstrates its established capability to meet federal pharmaceutical procurement requirements and support critical medical supply chains across the Defense Health enterprise.
Quick answers
Who was awarded contract SPE2DR26F0YH7?
SPE2DR26F0YH7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26F0YH7 worth?
The government has obligated $32,997 on SPE2DR26F0YH7.
Is contract SPE2DR26F0YH7 an order under another contract?
Yes. SPE2DR26F0YH7 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0YH7 competed?
The extent of competition for SPE2DR26F0YH7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award